Doc.AI vs Nebula Genomics vs Curecoin
What problem does this service solve?
Doc.AI is using blockchain and AI to enable consumers to control their biological and medical profile. | Nebula Genomics wants to use blockchain technology to address the challenges of genomic big data. | Curecoin uses tokenized incentives to assist in the collection of biomedical research data. |
Token Stats
Not Relevant | Not Relevant |
Company Description
Doc.AI is developing an AI powered blockchain platform for biological and medical data. Data will be secured with blockchain technology and AI will be used to generate insights from this data. Doc.AI hopes to empower individuals to take advantage of their medical, anatomic, and genetic data. They are launching NEURON, a decentralized artificial intelligence platform that will allow anyone to perform a data trial. Combining the power of blockchain and AI has the potential to have far reaching benefits for the entire healthcare industry. | Nebula Genomics is working to use blockchain to improve the process of identifying and sequencing genes. A better understanding of genomes would help cure diseases and could have numerous other benefits. | Curecoin is a digital currency that is designed to assist in the collection of biomedical research data. The network is powered by the CURE coin, and has a consensus mechanism that uses computing resources for protein folding; a process that simulates protein behavior. The project is associated with Stanford University. |